We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Nov 20
Janssen will commit around $604m and BARDA nearly $454m to support the ongoing Phase 3 ENSEMBLE trial programme
22 Oct 20
Interim data from Phase ½ study demonstrates that the two candidate vaccines induced enhanced immune response and are…
14 Oct 20
The financing is part of the World Bank Group’s $160bn package to help developing countries fight the Covid-19…
13 Oct 20
The trials affected by the event include the phase 3 ENSEMBLE trial for JNJ-78436735
21 Jul 20
The Covid-19 vaccine is currently under development and the agreement with the UK government is subject to clinical…
17 Jul 20
J&J is preparing to start human trials of its Covid-19 vaccine this month and is working to accelerate…
08 Jul 20
The funding will support the late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure and…
07 Jul 20
CureVac has reached a loan agreement with EIB for the development and production of vaccine candidate against SARS-CoV-2
17 Jun 20
The investment is aimed at strengthening Sanofi’s capability to advance the research and production of new advanced vaccines
21 Apr 20
Multiple sclerosis is a chronic disease that occurs when the immune system abnormally attacks the parts of nerve…